Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lactobacillus sakei MJM60958 as a Potential Probiotic Alleviated Non-Alcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet by Modulating Lipid Metabolism, Inflammation, and Gut Microbiota
Huong Thi Nguyen, Mingkun Gu, Pia Werlinger, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13436-13436
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment Options
Natalia G. Vallianou, Dimitris Kounatidis, Sotiria Psallida, et al.
Metabolites (2024) Vol. 14, Iss. 7, pp. 366-366
Open Access | Times Cited: 18
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
Ludovico Abenavoli, Giuseppe Guido Maria Scarlata, Emidio Scarpellini, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 594-594
Open Access | Times Cited: 28
Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies
Muthukumaran Jayachandran, Shen Qu
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 6, pp. 1189-1204
Closed Access | Times Cited: 26
The potential of short-chain fatty acid epigenetic regulation in chronic low-grade inflammation and obesity
Julia Kopczyńska, Magdalena Kowalczyk
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
An Updated Review on Probiotic Production and Applications
Guru Prasad Venkatesh, Kuruvalli Gouthami, Khajamohiddin Syed, et al.
Gastroenterology Insights (2024) Vol. 15, Iss. 1, pp. 221-236
Open Access | Times Cited: 7
Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease
Alejandra Mijangos-Trejo, Natalia Nuño‐Lámbarri, Varenka J. Barbero-Becerra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14918-14918
Open Access | Times Cited: 17
The role of intestinal flora in metabolic dysfunction-associated steatotic liver disease and treatment strategies
Lijun Wang, Jian Sun, Shu Cheng Chen, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Neoagarooligosaccharides improve non-alcoholic fatty liver disease by modulating lipid metabolism and Nrf2-related pathways
Subin Bae, Je Hyeon Lee, Su Jung Kim, et al.
Journal of Functional Foods (2025) Vol. 127, pp. 106737-106737
Closed Access
Impact of Lactobacillaceae supplementation on the multi-organ axis during MASLD
André A. Santos, Raquel Duarte, Madalena Duarte, et al.
Life Sciences (2024) Vol. 354, pp. 122948-122948
Open Access | Times Cited: 4
Meta-analysis of the effects of probiotics on hyperlipidemia
Yuanyue Yao, Qing Hong, Siqi Ding, et al.
Current Research in Food Science (2024) Vol. 9, pp. 100885-100885
Open Access | Times Cited: 4
Effect of different levels of Lactobacillus added to diets on fat deposition and meat quality of Sunit lambs
Yue Zhang, Min Zhang, Lin Su, et al.
Meat Science (2024) Vol. 213, pp. 109470-109470
Closed Access | Times Cited: 3
A study on the treatment effects of Crataegus pinnatifida polysaccharide on non-alcoholic fatty liver in mice by modulating gut microbiota
Ping Hao, Xiaonan Yang, Wen Yin, et al.
Frontiers in Veterinary Science (2024) Vol. 11
Open Access | Times Cited: 3
Assessing the in vivo ameliorative effects of Lactobacillus acidophilus KLDS1.0901 for induced non-alcoholic fatty liver disease treatment
Yanbo Wang, Zengbo Wang, Yang Wan, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 9
NAD metabolic therapy in metabolic dysfunction-associated steatotic liver disease: Possible roles of gut microbiota
Xinyi Lu, Rui Yang, Yu Chen, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109174-109174
Open Access | Times Cited: 2
Comparing the effects of empagliflozin and liraglutide on lipid metabolism and intestinal microflora in diabetic mice
Qiong Yang, Ling Deng, Changmei Feng, et al.
PeerJ (2024) Vol. 12, pp. e17055-e17055
Open Access | Times Cited: 2
Lactobacillus helveticus attenuates alcoholic liver injury via regulation of gut microecology in mice
Jiawen Lv, Guanjing Lang, Qiangqiang Wang, et al.
Microbial Biotechnology (2024) Vol. 17, Iss. 10
Open Access | Times Cited: 2
Sanguisorba officinalis L. Ameliorates Hepatic Steatosis and Fibrosis by Modulating Oxidative Stress, Fatty Acid Oxidation, and Gut Microbiota in CDAHFD-Induced Mice
Yunseong Nam, Myungsuk Kim, Saruul Erdenebileg, et al.
Nutrients (2023) Vol. 15, Iss. 17, pp. 3779-3779
Open Access | Times Cited: 6
Gut microbiota and metabolite interface-mediated hepatic inflammation
Ming Yang, Katina Massad, Eric T. Kimchi, et al.
Immunometabolism (2024) Vol. 6, Iss. 1, pp. e00037-e00037
Open Access | Times Cited: 1
Probiotics as Potential Therapy in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD)
Margalida Monserrat-Mesquida, Cristina Bouzas, Catalina M. Mascaró, et al.
Fermentation (2023) Vol. 9, Iss. 4, pp. 395-395
Open Access | Times Cited: 4
Lactobacillus helveticus Isolated from Raw Milk Improves Liver Function, Hepatic Steatosis, and Lipid Metabolism in Non-Alcoholic Fatty Liver Disease Mouse Model
Hyeonji Kim, Kippeum Lee, Ju-Yeon Kim, et al.
Microorganisms (2023) Vol. 11, Iss. 10, pp. 2466-2466
Open Access | Times Cited: 4
乳酸菌调控宿主脂肪代谢的研究进展
Zhong Chen, Jie Ma, Siting Xia, et al.
Scientia Sinica Vitae (2024)
Open Access | Times Cited: 1
Autoclaving-treated germinated brown rice relieves hyperlipidemia by modulating gut microbiota in humans
Chuanying Ren, Bin Hong, Shan Zhang, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 1
How far are we from an approved drug for nonalcoholic steatohepatitis?
Nahúm Méndez‐Sánchez, Shreya C. Pal, Jacqueline Córdova‐Gallardo
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 9, pp. 1021-1038
Closed Access | Times Cited: 3
Roles of gut microbes in metabolic-associated fatty liver disease
Chun‐Yao Chen, Han‐Chen Ho
Tzu Chi Medical Journal (2023)
Open Access | Times Cited: 2
Impact of culture medium on the interpretation of qRT-PCR data in HepG2 incubated with lactobacilli
Mária Nováková, Veronika Vyletelová, Barbora Hlubinová, et al.
Letters in Applied Microbiology (2024) Vol. 77, Iss. 6
Closed Access
Page 1 - Next Page

Scroll to top